U.K. Investment Firm Snaps Up Israeli Start-up Algatechnologies

Grovepoint Capital is paying an estimated $15 million to $20 million for the company, which fights the effects of aging.

comments Print
Kibbutz Ketura scored its second exit in three years this weekend when Britain's Grovepoint Capital agreed to buy control of its biotech start-up Algatechnologies.